GEJ ADENOCARCINOMA
Clinical trials for GEJ ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GEJ ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GEJ ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in humans testing a new cancer drug called AVA6103. The trial aims to find a safe dose and see if the drug shows early signs of helping patients with advanced solid tumors that have spread or cannot be removed by surgery. It will enroll adults with specifi…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug trial tests experimental treatment for tough tumors
Disease control Recruiting nowThis early-stage study is testing whether an experimental drug called NRM-823 is safe and can help control advanced cancers that have stopped responding to standard treatments. Researchers will give NRM-823 alone and combined with immunotherapy to about 150 adults with various so…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough stomach cancers: testing a Triple-Threat treatment
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or gastroesophageal cancer that has a specific marker called HER2-positive. The main goals are to find the safest and most effective dose of the new drug fruquintinib when added to two standard ca…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC